Some considerations of methodology and standardization of apolipoprotein A-I immunoassays.

No abstract is available for this paper.

• Publication year

  1983

• Venue

  Clinical Chemistry

• Publication date

  1983-03-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1093/CLINCHEM/29.3.415PMID 6402322
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antigen-antibody reactions in gels. IV. Types of reactions in coordinated systems of diffusion.

  2009cited by this paper
• Tangier disease: a structural defect in apolipoprotein A-I (apoA-I Tangier).

  1982cited by this paper
• Discriminative value of lipids and apoproteins in coronary heart disease.

  1982cited by this paper
• The covalent structure of apolipoprotein A-I from canine high density lipoproteins.

  1982cited by this paper
• Hepatic apo-A-I and apo-E and intestinal apo-A-I are synthesized in precursor isoprotein forms by organ cultures of human fetal tissues.

  1982cited by this paper
• Radioimmunoassay of apolipoprotein A-i. application of a non-ionic detergent (Tween-20) and solid-phase staphylococcus.

  1982cited by this paper
• Separation of the apoprotein components of human serum high density lipoprotein: chromatofocusing, a new simple technique.

  1982cited by this paper
• The process of dissolving apolipoprotein A-I in an aqueous buffer.

  1982cited by this paper
• Influence of triglyceride-rich lipoproteins on nephelometry of apolipoprotein A-I.

  1982cited by this paper
• Simultaneous measurement of plasma apolipoproteins A-I and B by electroimmunoassay.

  1982cited by this paper
• Conformational transitions in serum high density apoproteins of hypercholesterolemic monkeys.

  1982cited by this paper
• Plasma apolipoprotein A-1 absence associated with a marked reduction of high density lipoproteins and premature coronary artery disease.

  1982cited by this paper
• Changes in the distribution and composition of plasma high density lipoproteins after ingestion of fat.

  1982cited by this paper
• Characterization, cell-free synthesis, and processing of apolipoprotein A-I of rat high-density lipoproteins.

  1981cited by this paper
• Determination of high-density lipoproteins: comparison of HDL-cholesterol, HDL-phospholipids, and HDL-apolipoprotein A-I.

  1981cited by this paper
• Human plasma high density apolipoprotein A-I: effect of protein-protein interactions on the spontaneous formation of a lipid-protein recombinant.

  1981cited by this paper
• [Accuracy of HDL-cholesterol and HDL-apolipoprotein A-I determinations after phosphotungstate/MgCl2-precipitation of apolipoprotein B-containing lipoproteins (author's transl)].

  1981cited by this paper
• Quantitative determination of human plasma apolipoprotein A-I by laser immunonephelometry.

  1981cited by this paper
• Determination of apolipoprotein A-I by kinetic nephelometry.

  1981cited by this paper
• Metabolism of apolipoprotein A-I of chylomicrons in rats and humans.

  1981cited by this paper
• Loss of A-Apoprotein Immunoreactivity during High-Density Lipoprotein Separation

  1981cited by this paper
• Properties of apolipoprotein B in urea and in aqueous buffers. The use of glutathione and nitrogen in its solubilization.

  1981cited by this paper
• Immunonephelometric assay of human apolipoprotein AI.

  1980cited by this paper
• Effect of storage on the measurement of apolipoproteins A-I and A-II by radial immunodiffusion.

  1980cited by this paper
• Isolation and characterization of the amyloid-related apoprotein (SAA) from human high density lipoprotein.

  1980cited by this paper
• The effect of D-thyroxine on lipoprotein lipids and apolipoproteins in primary type IIa hyperlipoproteinemia.

  1980cited by this paper
• The antigenic structure of apolipoprotein A-I in human high density lipoproteins. Radioimmunoassay using surface-specific antibodies.

  1980cited by this paper
• Serum apolipoprotein levels in relation to acute myocardial infarction and its risk factors. Apolipoprotein A-I levels in male survivors of myocardial infarction.

  1980cited by this paper
• The measurement of apolipoprotein A-I in human plasma by electroimmunoassay.

  1980cited by this paper
• Physical, chemical, and immunochemical studies of apolipoprotein A-I from pigeon plasma high density lipoproteins.

  1980cited by this paper
• Apoproteins and lipids as discriminators of severity of coronary heart disease.

  1980cited by this paper
• Tween-20 increases the immunoreactivity of apolipoprotein A-I in plasma.

  1980cited by this paper
• Association of coronary atherosclerosis with hyperapobetalipoproteinemia [increased protein but normal cholesterol levels in human plasma low density (beta) lipoproteins].

  1980cited by this paper
• Electroimmunoassay and Radioimmunoassay for the Quantitation of High Density Apolipoproteins A-I and A-II

  1980cited by this paper
• Effects of amount and type of dietary fat on serum lipids, lipoproteins and apolipoproteins in man. A controlled 8-week trial.

  1980cited by this paper
• Coronary heart disease prevalence and other clinical features in familial high-density lipoprotein deficiency (Tangier disease).

  1980cited by this paper
• The distinction between the exposed regions and the buried regions of apoproteins in high density lipoproteins by their reactivities with pronase.

  1980cited by this paper
• Properties of lipid . apolipoprotein association products. Complexes of dimyristoyl phosphatidylcholine and human apo A-1.

  1980cited by this paper
• Reduction of high density lipoprotein cholesterol and apoliproprotein A-I concentrations by a lipid-lowering diet.

  1980cited by this paper
• A-Imilano apoprotein. Isolation and characterization of a cysteine-containing variant of the A-I apoprotein from human high density lipoproteins.

  1980cited by this paper
• Isoproteins of human apolipoprotein A-I demonstrated in plasma and intestinal organ culture.

  1980cited by this paper
• Comparison of immunonephelometry and electroimmunoassay for estimation of plasma apolipoprotein A-I.

  1980cited by this paper
• Presence of "free" apoA-I in serum: implications for immunological quantification of HDL and its apoproteins.

  1980cited by this paper
• Studies on the polymorphism of human apolipoprotein A-I.

  1980cited by this paper
• Nephelometry of apolipoprotein B in human serum.

  1979cited by this paper
• Immunological relationship between bile lipoprotein complex and high density lipoprotein.

  1979cited by this paper
• Response of plasma lipoproteins and acute phase proteins to myocardial infarction.

  1979cited by this paper
• Are apolipoproteins better discriminators than lipids for atherosclerosis?

  1979cited by this paper
• Isolation and characterization of high density lipoprotein apoproteins in the non-human primate (vervet).

  1979cited by this paper
• Immunochemical determination of human apolipoprotein A-I by laser nephelometry.

  1979cited by this paper
• Apoprotein A metabolism in Tangier disease.

  1978cited by this paper
• Quantitation of the two major apoproteins of human high density lipoproteins by solid phase radioimmunoassay.

  1978cited by this paper
• Effect of pressure and ionic strength on the self-association of Apo-A-I from the human high density lipoprotein complex.

  1978cited by this paper
• Isolation and characterization of two threonine-poor apolipoproteins of human plasma high density lipoproteins.

  1978cited by this paper
• The amino acid sequence of human APOA-I, an apolipoprotein isolated from high density lipoproteins.

  1978cited by this paper
• The quantitative determination of apolipoprotein A-I (apo-lp-Gln I) in human serum by radial immunodiffusion assay (RID).

  1978cited by this paper
• Metabolism of apolipoproteins A‐I and A‐ll and its influence on the high density lipoprotein subfraction distribution in males and females

  1978cited by this paper
• Quantitation of the major apoproteins of human high density lipoproteins by solid phase radioimmunoassay

  1978cited by this paper
• HDL-cholesterol, apolipoproteins A1 and B. Age and index body weight.

  1978cited by this paper
• Cross-linking studies of the self-association properties of apo-A-I and apo-A-II from human high density lipoprotein.

  1978cited by this paper
• Abnormal concentration and anomalous distribution of apolipoprotein A-I in Tangier disease.

  1978cited by this paper
• Metabolism of apolipoprotein A-I in healthy young adults.

  1978cited by this paper
• The lipoprotein abnormality in Tangier disease: quantitation of A apoproteins.

  1977cited by this paper
• Apoprotein content of plasma lipoproteins of the rat separated by gel chromatography or ultracentrifugation.

  1977cited by this paper
• Measurement of the apoproteins of human serum lipoproteins by rocket immunoelectrophoresis.

  1977cited by this paper
• An approach to immunoassay.

  1977cited by this paper
• Self-association of apo-C-I from the human high density lipoprotein complex.

  1977cited by this paper
• Analysis of rat serum apolipoproteins by isoelectric focusing. I. Studies on the middle molecular weight subunits.

  1977cited by this paper
• Use of antibody specificity to study the surface disposition of apoprotein A-I on human high density lipoproteins.

  1977cited by this paper
• Characterization of baboon plasma high-density lipoproteins and of their major apoproteins.

  1977cited by this paper
• The measurement of apolipoprotein A-I and A-II levels in men and women by immunoassay.

  1977cited by this paper
• Measurement of human high density lipoprotein apolipoprotein A-1 in serum by radioimmunoassay.

  1976cited by this paper
• Interaction of the apoproteins of very low density and high density lipoproteins with synthetic phospholipids.

  1976cited by this paper
• Quantitation of apolipoprotein A-I of human plasma high density lipoprotein.

  1976cited by this paper
• Changes in electrophoretic mobilities of alpha-and beta-lipoproteins as a result of plasma delipidation.

  1976cited by this paper
• Studies on human serum high density lipoproteins. Self-association of apolipoprotein A-I in aqueous solutions.

  1976cited by this paper
• Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electroimmunoassays.

  1976cited by this paper
• Conformational and thermodynamic properties of apo A-1 of human plasma high density lipoproteins.

  1976cited by this paper
• Plasma apolipoprotein A levels in healthy human adults.

  1975cited by this paper
• Isolation and partial characterization of the major apolipoprotein component of bovine serum high density lipoprotein.

  1975cited by this paper
• Radioimmunoassay of human high density lipoprotein apo-protein A-1.

  1975cited by this paper
• Familial hyperlipoproteinemia type III: Deficiency of a specific apolipoprotein (APO E‐III) in the very‐low‐density lipoproteins

  1975cited by this paper
• The self-association of the apo-Gln-I and apo-Gln-II polypeptides of human high density serum lipoproteins.

  1975cited by this paper
• Structural and compositional changes attending the ultracentrifugation of very low density lipoproteins.

  1975cited by this paper
• The primary structure of high density apolipoprotein-glutamine-I.

  1974cited by this paper
• The molecular properties of ApoA-I from human high density lipoprotein.

  1974cited by this paper
• The structure of human high density lipoprotein and the levels of apolipoprotein A-I in plasma as determined by radioimmunoassay.

  1974cited by this paper
• A rapid electrophoretic technique for identification of subunit species of apoproteins in serum lipoproteins.

  1973cited by this paper
• A study of the cystine-containing apolipoprotein of human plasma high density lipoproteins: characterization of cyanogen bromide and tryptic fragments.

  1972cited by this paper
• A protein cofactor of lecithin:cholesterol acyltransferase.

  1972cited by this paper
• Electroimmuno assay.

  1972cited by this paper
• Further characterization of the polymorphic forms of a human high density apolipoprotein, apoLP-Gln-I (apoA-I).

  1972cited by this paper
• On the subunit structure of the protein of human serum high density lipoprotein. I. A study of its major polypeptide component (Sephadex, fraction 3).

  1972cited by this paper
• [Demonstration and separation of the protein components of human serum alpha-lipoproteins].

  1972cited by this paper
• Solubility in aqueous solutions of ethanol of the small molecular weight peptides of the serum very low density and high density lipoproteins: relevance to the recovery problem during delipidation of serum lipoproteins.

  1971cited by this paper
• Precipitation of 125 I-labeled lipoproteins with specific polypeptide antisera. Evidence for two populations with differing polypeptide compositions in human high density lipoproteins.

  1971cited by this paper
• Removal of lipids from human plasma low-density lipoprotein by detergents.

  1971cited by this paper
• Monoiodoinsulin: demonstration of its biological activity and binding to fat cells and liver membranes.

  1971cited by this paper
• Studies of the proteins in human plasma very low density lipoproteins.

  1969cited by this paper
• An enzymic method for the trace iodination of immunoglobulins and other proteins.

  1969cited by this paper

• Body Fat Distribution

  2019cites this paper
• Apolipoprotein mediates soft-shelled turtle systemic septicemia spherical virus (STSSSV) infection

  2017cites this paper
• Efecto del género y parámetros antropométricos en marcadores de estrés oxidativo e inflamación en situación postprandial

  2015cites this paper
• BMI of the firstborn offspring at age 12 reflects maternal LDL and HDL cholesterol levels at term pregnancy and postpartum

  2014cites this paper
• Efecto metabólico del ejercicio físico regular en la población sana

  2013cites this paper
• Metabolic effects of regular physical exercise in healthy population

  2013cites this paper
• Increased oxidative stress levels and normal antioxidant enzyme activity in circulating mononuclear cells from patients of familial hypercholesterolemia.

  2010cites this paper
• Differential lipid profile and hormonal response in type 2 diabetes by exogenous insulin aspart versus the insulin secretagogue repaglinide, at the same glycemic control

  2009cites this paper
• Evaluation of clinical diagnosis criteria of familial ligand defective apoB 100 and lipoprotein phenotype comparison between LDL receptor gene mutations affecting ligand-binding domain and the R3500Q mutation of the apoB gene in patients from a South European population.

  2008cites this paper
• Classical cardiovascular risk factors according to fasting plasma glucose levels.

  2008cites this paper
• Hypolipidaemic effects of fenofibrate and fasting in the herbivorous grass carp ( Ctenopharyngodon idella) fed a high-fat diet.

  2008cites this paper
• Quantification of serum apolipoprotein B by infrared spectroscopy

  2007cites this paper
• Efectividad de un programa de prevención secundaria de la arteriosclerosis en el control de las dislipemias en pacientes con enfermedad arterial coronaria

  2006cites this paper
• Efecto del género y de la obesidad en la lipemia posprandial en sujetos sanos normolipidémicos no diabéticos y sujetos con hiperlipemia familiar combinada

  2006cites this paper
• Effects of a Controlled Program of Moderate Physical Exercise on Insulin Sensitivity in Nonobese, Nondiabetic Subjects

  2006cites this paper
• Gold-labeled nanoparticle-based immunoresonance scattering spectral assay for trace apolipoprotein AI and apolipoprotein B.

  2006cites this paper
• Determinantes de la lipemia posprandial medida como perfil diurno de triglicéridos en personas no diabéticas con normolipemia

  2005cites this paper
• Polyclonal Antibodies against Formaldehyde-modified Apolipoprotein A-l An Approach to Circumventing Fixation-induced Loss of Antigenicity in Immunocytochemistry Barbel Harrach

  2005cites this paper
• Acute-Phase Processes in Pigs Decreases during Experimentally Induced The Concentration of Apolipoprotein A-I

  2005cites this paper
• The Concentration of Apolipoprotein A-I Decreases during Experimentally Induced Acute-Phase Processes in Pigs

  2005cites this paper
• ) in serum from a populationof 448 healthy subjects ( 265 men and 183 women , ages 18 to 61 years ) by a kinetic immunonephelometric procedure

  2004cites this paper
• CompetitiveEnzyme InhibitionImmunoassayof ApolipoproteinA-I : Use of Monoclonal Antibodies

  2004cites this paper
• Efecte del tractament amb difenilhidantoïna sobre el perfil lipoproteic i la susceptibilitat a l'arteriosclerosi en models murídics

  2004cites this paper
• Immunoturbidimetric Method for Routine Determinations of Apolipoproteins A-I , AIl , and B in Normo-and Hyperlipemic Sera Compared with Immunonephelometry

  2004cites this paper
• Estudio del defecto familiar de unión de la apolipoproteína B100 en una población mediterránea

  2004cites this paper
• Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population

  2003cites this paper
• Influencia del depósito de grasa abdominal en la respuesta terapéutica a atorvastatina en mujeres con hipercolesterolemia familiar heterocigota

  2003cites this paper
• Asociación de factores lipídicos, genotipo de APOE y tipos de mutación del gen del receptor de LDL con el infarto agudo de miocardio en sujetos con hipercolesterolemia familiar heterocigota

  2002cites this paper
• Genetic diagnosis of familial hypercholesterolemia in a South European outbreed population: influence of low-density lipoprotein (LDL) receptor gene mutations on treatment response to simvastatin in total, LDL, and high-density lipoprotein cholesterol.

  2001cites this paper
• Cuantificación de insulinorresistencia con los valores de insulina basal e índice HOMA en una población no diabética

  2001cites this paper
• Importance of HDL cholesterol levels and the total/ HDL cholesterol ratio as a risk factor for coronary heart disease in molecularly defined heterozygous familial hypercholesterolaemia.

  2001cites this paper
• Lipid and lipoprotein levels in premenopausal systemic lupus erythematosus patients

  2001cites this paper
• Influencia de las mutaciones HF Valencia 1 y 2 del gen del receptor de LDL sobre la respuesta terapéutica a simvastatina en sujetos con hipercolesterolemia familiar heterocigota caracterizada molecularmente

  2001cites this paper
• Lipoprotein phenotype and insulin resistance in familial combined hyperlipidemia.

  2000cites this paper
• Apolipoproteins A–I, A–II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study

  2000cites this paper
• A study of insulin resistance using the minimal model in nondiabetic familial combined hyperlipidemic patients.

  1998cites this paper
• Genetic variation at the apoA-IV gene locus and response to diet in familial hypercholesterolemia.

  1998cites this paper
• [Risk factors of arteriopathy of the lower extremities: lipid and not lipid factors].

  1997cites this paper
• Analysis of Apolipoproteins

  1996cites this paper
• Heterogeneity of high-density lipoproteins and apolipoprotein A-I as related to quantification of apolipoprotein A-I.

  1996cites this paper
• Heterogeneity of high-density lipoprotein particles and insulin output during oral glucose tolerance test in men with coronary artery disease

  1996cites this paper
• Influence of worksite environmental tobacco smoke on serum lipoprotein profiles of female nonsmokers.

  1995cites this paper
• Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma.

  1995cites this paper
• Effects of fish oil fatty acids on low density lipoprotein size, oxidizability, and uptake by macrophages.

  1995cites this paper
• Measurement of apolipoproteins B and A by radial immunodiffusion: methodological assessment and clinical applications.

  1994cites this paper
• Changes in plasma lipoprotein during the oestrous cycle of the bitch.

  1994cites this paper
• Analysing canine lipoproteins

  1994cites this paper
• Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47.

  1994cites this paper
• Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

  1994cites this paper
• Plasma lipoprotein lipids in five different breeds of dogs.

  1993cites this paper
• Comparison of Apolipoprotein A-I Values Assayed in Lyophilized and Frozen Pooled Human Sera by a Non-Immunochemical Electrophoretic Method and by Immunoassay

  1993cites this paper
• Enzyme‐linked immunosorbent assay to measure apolipoproteins Al and B secreted by a human hepatic carcinoma cell line (Hep G2)

  1992cites this paper
• Reference values for apolipoproteins A-I and B in healthy subjects, by age.

  1992cites this paper
• Modulation of lipoprotein production in Hep G2 cells by fenofibrate and clofibrate.

  1992cites this paper
• Silver-enhanced radial immunodiffusion assay of plasma apolipoproteins.

  1992cites this paper
• Pre-beta high-density lipoprotein determined by immunoblotting with chemiluminescent detection.

  1992cites this paper
• Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol.

  1992cites this paper
• Procedure for development of an enzyme-linked immunosorbent assay. Development of an assay for human apolipoprotein A-I.

  1992cites this paper
• Relation of Arteriographically Defined Coronary Artery Disease to Serum Lipoprotein Particles Mapped With Monoclonal Antibodies

  1991cites this paper
• Lipid and apolipoprotein levels in an Australian community

  1991cites this paper
• Comparison of three species of dietary fish: effects on serum concentrations of low-density-lipoprotein cholesterol and apolipoprotein in normotriglyceridemic subjects.

  1991cites this paper
• Immunoturbidimetric method for routine determinations of apolipoproteins A-I and B.

  1991cites this paper
• Plasma high density lipoprotein particle size alteration by simvastatin treatment in patients with hypercholesterolaemia.

  1991cites this paper
• Clinical applications and standardization of apolipoprotein measurements in the diagnostic workup of lipid disorders.

  1991cites this paper
• International study on the comparability of Apo A-1 and Apo B methods.

  1990cites this paper
• Differential electroimmunoassay of human LpA-I lipoprotein particles on ready-to-use plates.

  1990cites this paper
• Effect of chronic renal failure on high-density lipoprotein kinetics.

  1990cites this paper
• Effect of different insulin regimens on plasma lipoprotein and apolipoprotein concentrations in patients with non-insulin-dependent diabetes mellitus.

  1990cites this paper
• Polyclonal antibodies against formaldehyde-modified apolipoprotein A-I. An approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry.

  1990cites this paper
• [Use of 6 serum pools in standardization of the determination of apolipoproteins AI and B in the human serum].

  1990cites this paper
• Impact of protein measurements on standardization of assays of apolipoproteins A-I and B1.

  1990cites this paper
• Immunological assays of apolipoproteins in plasma: methods and instrumentation.

  1990cites this paper
• Effects of analytical method and lyophilized sera on measurements of apolipoproteins A-I and B: an international survey.

  1990cites this paper
• [The dual protective effect of fish oil in preventing coronary diseases].

  1989cites this paper
• Plasma and Lipoprotein Lipids and Apolipoproteins AI, AII and B in Patients with Chronic Airflow Limitation

  1989cites this paper
• Comparative effects of prazosin and propranolol on blood lipid profiles in hypertensive, hypercholesterolemic patients. Preliminary results.

  1989cites this paper
• Modification of lipoprotein patterns and retardation of atherogenesis by a fish oil supplement to a hyperlipidemic diet for swine.

  1989cites this paper
• Quantification of apolipoprotein A-1 in cow serum by single radial immunodiffusion.

  1989cites this paper
• Quantitative determination of apolipoprotein B in bovine serum by radial immunodiffusion.

  1989cites this paper
• Apolipoproteins: Biochemistry, methods and clinical significance

  1989cites this paper
• Effect of prazosin treatment on carbohydrate and lipoprotein metabolism in patients with hypertension.

  1989cites this paper
• Apolipoprotein assays: methodological considerations and studies in non-insulin-dependent diabetes treated by diet, glibenclamide and insulin.

  1989cites this paper
• Lipoprotein analysis. Early methods in the diagnosis of atherosclerosis.

  1989cites this paper
• Changes in the immunoreactivity of Apo A-I during storage.

  1989cites this paper
• Mechanisms responsible for increasing immunoreactivity of apolipoprotein A-I with storage: the role of oxidation.

  1989cites this paper
• Comparison of methods for the measurement of apoproteins A1 and B in serum.

  1989cites this paper
• Suppression of alimentary lipemia in man by a prostaglandin analogue (enprostil).

  1989cites this paper
• A simple method for the measurement of total and glycated apolipoprotein B and its relevance to apolipoprotein-B metabolism in diabetes mellitus.

  1989cites this paper
• Comparison of two commercial nephelometric methods for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays.

  1989cites this paper
• MechanismsResponsible for IncreasingImmunoreactivity of Apolipoprotein A-I withStorage: the Roleof Oxidation

  1989cites this paper
• Coffee, blood pressure and plasma lipids: a randomized controlled trial.

  1989cites this paper
• Electroimmuno- and immunonephelometric assays of apolipoprotein A-I by using a mixture of monoclonal antibodies.

  1988cites this paper
• Comparison of commercial kits for apoprotein A-I and apoprotein B with standardized apoprotein A-I and B radioimmunoassays performed at the Northwest Lipid Research Center.

  1988cites this paper
• Standardization of lipid, lipoprotein, and apolipoprotein measurements.

  1988cites this paper
• Electroimmunoassay of human serum lipoproteins containing Apo A-I by monoclonal antibodies.

  1988cites this paper
• Apolipoprotein measurements in clinical biochemistry and their utility vis-a-vis conventional assays.

  1988cites this paper
• Immunoturbidimetric method for routine determinations of apolipoproteins A-I, A-II, and B in normo- and hyperlipemic sera compared with immunonephelometry.

  1988cites this paper
• A new micromethod for routine measurement of serum LDL-apolipoprotein B.

  1988cites this paper
• Rapid quantitative apolipoprotein analysis by gradient ultracentrifugation and reversed-phase high performance liquid chromatography.

  1988cites this paper
• Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.

  1988cites this paper